Literature DB >> 17498049

Synovial mast cells: role in acute and chronic arthritis.

Peter A Nigrovic1, David M Lee.   

Abstract

Mast cells reside in the normal synovium and increase strikingly in number in rheumatoid arthritis and other joint diseases. Given the broad spectrum of activity of this lineage, it has for decades been considered probable that mast cells are involved in the pathophysiology of synovitis. Recent work in murine arthritis has substantiated this suspicion, showing that mast cells can contribute importantly to the initiation of inflammatory arthritis. However, the role of the greatly expanded population of synovial mast cells in established arthritis remains unknown. Here we review the current understanding of mast cell function in acute arthritis and consider the potentially important influence of this cell on key processes within the chronically inflamed synovium, including leukocyte recruitment and activation, fibroblast proliferation, angiogenesis, matrix remodeling, and injury to collagen and bone. We also consider recent evidence supporting an immunomodulatory or anti-inflammatory role for mast cells as well as pharmacologic approaches to the mast cell as a therapeutic target in inflammatory arthritis.

Entities:  

Mesh:

Year:  2007        PMID: 17498049     DOI: 10.1111/j.1600-065X.2007.00506.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  47 in total

Review 1.  Approaches for analyzing the roles of mast cells and their proteases in vivo.

Authors:  Stephen J Galli; Mindy Tsai; Thomas Marichal; Elena Tchougounova; Laurent L Reber; Gunnar Pejler
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

2.  Mast cell stabilization: novel medication for obesity and diabetes.

Authors:  Jing Wang; Guo-Ping Shi
Journal:  Diabetes Metab Res Rev       Date:  2011-11       Impact factor: 4.876

3.  Regulation of human neutrophil Fcγ receptor IIa by C5a receptor promotes inflammatory arthritis in mice.

Authors:  Naotake Tsuboi; Thomas Ernandez; Xun Li; Hiroshi Nishi; Xavier Cullere; Divya Mekala; Melissa Hazen; Jörg Köhl; David M Lee; Tanya N Mayadas
Journal:  Arthritis Rheum       Date:  2011-02

Review 4.  Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis.

Authors:  Stephen J Galli; Mindy Tsai
Journal:  J Dermatol Sci       Date:  2007-11-19       Impact factor: 4.563

5.  IL-33/ST2 axis promotes mast cell survival via BCLXL.

Authors:  Jun-Xia Wang; Shinjiro Kaieda; Sarah Ameri; Nadia Fishgal; Daniel Dwyer; Anthony Dellinger; Christopher L Kepley; Michael F Gurish; Peter A Nigrovic
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

6.  The association between synovial fluid serine proteinase activity and response to intra-articular corticosteroid injection in psoriatic arthritis.

Authors:  Fatima Abji; Justine Yang Ye; Richard J Cook; Katerina Oikonomopoulou; Vinod Chandran
Journal:  Clin Rheumatol       Date:  2020-02-25       Impact factor: 2.980

7.  Lansiumamide B and SB-204900 isolated from Clausena lansium inhibit histamine and TNF-α release from RBL-2H3 cells.

Authors:  Takuya Matsui; Chihiro Ito; Hiroshi Furukawa; Tadashi Okada; Masataka Itoigawa
Journal:  Inflamm Res       Date:  2013-01-17       Impact factor: 4.575

Review 8.  Mast cells as regulators of adaptive immunity to tumours.

Authors:  A Wasiuk; V C de Vries; K Hartmann; A Roers; R J Noelle
Journal:  Clin Exp Immunol       Date:  2008-12-05       Impact factor: 4.330

Review 9.  Angiogenesis and its targeting in rheumatoid arthritis.

Authors:  Zoltán Szekanecz; Alisa E Koch
Journal:  Vascul Pharmacol       Date:  2009-02-13       Impact factor: 5.773

10.  Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.

Authors:  Jacques Tebib; Xavier Mariette; Pierre Bourgeois; René-Marc Flipo; Philippe Gaudin; Xavier Le Loët; Paul Gineste; Laurent Guy; Colin D Mansfield; Alain Moussy; Patrice Dubreuil; Olivier Hermine; Jean Sibilia
Journal:  Arthritis Res Ther       Date:  2009-06-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.